Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 28, 2008; 14(32): 5025-5031
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5025
Table 1 Patient demographic, clinical and operative details
Parametersn
Age (yr; mean ± SD, range)59 ± 11 (33-78)
Male10
Female8
Primary tumor
Colorectal cancer12
Benign liver lesions2
Renal carcinomas1
Prostate carcinoma1
Cholangiocarcinoma1
Pseudopapillary pancreas tumor1
Operation
Right hemi-hepatectomy7
Left hemi-hepatectomy4
Extended right hemi-hepatectomy2
Right lateral sectorectomy2
Extended left hemi-hepatectomy1
Left lateral sectorectomy1
Non-anatomic resection1
Table 2 Mice & cell transplantation details
Treatment groupsMouse groupIP injectionNo. of mice
Negative control (Hepatocyte only)15 x 106 hepatocytes3
Positive control 1 (HT-29 only)25000 HT-29 cells3
3100 000 HT-29 cells3
4500 000 HT-29 cells3
52 million HT-29 cells3
Positive control 2 (Hepatocytes + HT-29)65 million hepatocytes + 5000 HT-293
75 million hepatocytes + 100 000 HT-293
85 million hepatocytes + 500 000 HT-293
95 million hepatocytes + 2 million HT-293
Bead (Hepatocyte + HT-29)105 million hepatocytes + 5000 HT-293
115 million hepatocytes + 100 000 HT-293
125 million hepatocytes + 500 000 HT-293
135 million hepatocytes + 2 million HT-293
Table 3 Tumor growth
Treatment groupsIP injectionMouse with tumourPercentage expression (%)
Negative control (Hepatocyte only)5 x 106 hepatocytes0/30
Positive control 1 (HT-29 only)5000 HT-29 cells0/30
100 000 HT-29 cells1/3101
500 000 HT-29 cells2/367
2 million HT-29 cells3/3100
Positive control 2 (Hepatocytes + HT-29)5 million hepatocytes + 5000 HT-290/30
5 million hepatocytes + 100 000 HT-290/30
5 million hepatocytes + 500 000 HT-293/3100
5 million hepatocytes + 2 million HT-292/367
Bead (Hepatocyte + HT-29)5 million hepatocytes + 5000 HT-290/30
5 million hepatocytes + 100 000 HT-290/30
5 million hepatocytes + 500 000 HT-290/30
5 million hepatocytes + 2 million HT-290/30